Skip to main content

Table 1 Patient demographics

From: Implementing a comprehensive translational oncology platform: from molecular testing to actionability

  Breast cancer (n = 19) Prostate cancer (n = 18) Pancreatic cancer (n = 1) Total (n = 38)
Gender
 Male 0 18 1 19
 Female 19 0 0 19
Age in years (median, range) 56
(35–71)
68
(56–80)
82 65
(35–82)
Prior therapies (median, range) 1.5
(0–14)
4
(0–9)
1 3
(0–14)
ECOG PS
 0–1 16 18 1 31
 ≥ 2 3 0 0 3
Research biopsy performed 15 12 1 28
Biopsy cellularity % (median, range) 70
(15–80)
75
(50–90)
80 70
(15–90)
Number of cores (median, range) 5
(3–10)
4.5
(2–7)
20 6
(2–20)